NCT02665286View on ClinicalTrials.gov

Orphenadrine and Methocarbamol for LBP

PHASE4CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

May 31, 2017

Conditions
Low Back Pain
Interventions
DRUG

Orphenadrine

Orphenadrine 100mg PO BID x 7 days

DRUG

Methocarbamol

Methocarbamol 750mg 1-2 tabs po TID x 7 days

DRUG

Naproxen

Naproxen 500mg PO BID x 7 days

DRUG

Placebo

1/2 of placebo packages will be dosed to match methocarbamol: 1-2 tabs po TID x 7days 1/2 of placebo packages will be dosed to match orphenadrine: 1 tab PO BID x 7 days

Trial Locations (1)

10467

Montefiore Medical Center, The Bronx

All Listed Sponsors
lead

Montefiore Medical Center

OTHER

NCT02665286 - Orphenadrine and Methocarbamol for LBP | Biotech Hunter | Biotech Hunter